Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Pharmashot Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1022473214457348096.png) PharmaShots - Incisive news in X shots [@Pharmashot](/creator/twitter/Pharmashot) on x 2260 followers
Created: 2025-07-03 10:38:47 UTC

mAbxience Receives the EC’s Approval for Denbrayce and Izamby (Biosimilar, Xgeva and Prolia)
#mabxience #denbrayce #izamby #prolia #xgeva #denosumab #amgen #biosimilar 


![](https://pbs.twimg.com/card_img/1940721922645676032/tJbFrcfo?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1940721880262234271/c:line.svg)

**Related Topics**
[$amgn](/topic/$amgn)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Pharmashot/status/1940721880262234271)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Pharmashot Avatar PharmaShots - Incisive news in X shots @Pharmashot on x 2260 followers Created: 2025-07-03 10:38:47 UTC

mAbxience Receives the EC’s Approval for Denbrayce and Izamby (Biosimilar, Xgeva and Prolia) #mabxience #denbrayce #izamby #prolia #xgeva #denosumab #amgen #biosimilar

XX engagements

Engagements Line Chart

Related Topics $amgn stocks healthcare

Post Link

post/tweet::1940721880262234271
/post/tweet::1940721880262234271